📊 Financial Update: This funding is integral to optimizing our cash flow. It strategically positions us for an upcoming capital increase scheduled for the first half of 2024—a pivotal step in our Series A initiative.
KEY DETAILS REGARDING THIS FINANCING
✔The current Seed Investment loan is a direct result of the successful capital increase executed last June, constituting the second seed phase, with the initial phase having been completed in 2022.
✔Noteworthy, this loan is reinforced by the backing of the Invest EU Innovation & Digitalization European Guarantee Fund, implemented by the European Investment Fund (EIF). Its covers up to 40% of the total loan amount.
BioMAdvanced Diagnostics